2024
Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery Method
Laffel L, Sherr J, Liu J, Wolf W, Bispham J, Chapman K, Finan D, Titievsky L, Liu T, Hagan K, Gaglia J, Chandarana K, Pettus J, Bergenstal R. Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery Method. Diabetes Care 2024, 48: 273-278. PMID: 39699995, PMCID: PMC11770157, DOI: 10.2337/dc24-1474.Peer-Reviewed Original Research
2021
Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation
Perkins BA, Sherr JL, Mathieu C. Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation. Science 2021, 373: 522-527. PMID: 34326234, DOI: 10.1126/science.abg4502.Peer-Reviewed Original ResearchConceptsInsulin therapySelf-care burdenSufficient glycemic controlType 1 diabetesRapid insulin analoguesInsulin delivery methodsInsulin delivery routeBroad clinical implementationMost patientsGlycemic controlGlycemic managementPharmacological advancesInsulin analoguesPharmacological solutionsInsulin pumpActivity monitorType 1Weight gainInsulin effectGlucose monitoringTherapyClinical implementationDelivery methodsInsulin moleculeKey metabolites
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply